# Filing Detail

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-14-266334
Filing Date
2014-07-11
Accepted
2014-07-11 13:55:22
Documents
7
Period of Report
2014-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q/A | d722469d10qa.htm | 10-Q/A | 27598
| Complete submission text file | 0001193125-14-266334.txt |  | 4662053

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL INSTANCE DOCUMENT | scyx-20140331.xml | EX-101.INS | 627855
3 | XBRL TAXONOMY EXTENSION SCHEMA | scyx-20140331.xsd | EX-101.SCH | 64103
4 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | scyx-20140331_cal.xml | EX-101.CAL | 61129
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | scyx-20140331_def.xml | EX-101.DEF | 198717
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | scyx-20140331_lab.xml | EX-101.LAB | 406487
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | scyx-20140331_pre.xml | EX-101.PRE | 316692

Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36365 | Film No.: 14971337
SIC: 2834 Pharmaceutical Preparations